Close

Biogen (BIIB) Raised Prices Again on MS Drugs, Cowen Notes

August 25, 2015 9:46 AM EDT Send to a Friend
Cowen analyst Eric Schmidt noted that third-party sources indicate Biogen (NASDAQ: BIIB) enacted a 6.0% price hike on Tecfidera, Avonex ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login